Cargando…
Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial
BACKGROUND: Clinical practice guidelines recommend administering antenatal corticosteroids (ACS), either betamethasone or dexamethasone, to women at risk of preterm birth at less than 35 weeks’ gestation. If women remain at risk of preterm birth seven or more days after an initial course of ACS, mos...
Autores principales: | Hofer, Olivia J., Harding, Jane E., Tran, Thach, Crowther, Caroline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863260/ https://www.ncbi.nlm.nih.gov/pubmed/35192656 http://dx.doi.org/10.1371/journal.pone.0263927 |
Ejemplares similares
-
Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol
por: Crowther, Caroline A, et al.
Publicado: (2013) -
Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm labor
por: Tehrani, Hatav Ghasemi, et al.
Publicado: (2014) -
Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy
por: Sarumi, Mojirayo A., et al.
Publicado: (2019) -
Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: A randomized trial comparing betamethasone and dexamethasone
por: Danesh, Azar, et al.
Publicado: (2012) -
Effects of single course and multicourse betamethasone prior to birth in the prognosis of the preterm neonates: A randomized, double-blind placebo-control clinical trial study
por: Atarod, Zoleykha, et al.
Publicado: (2014)